Major challenges and perspectives in the diagnostics and treatment of dermatophyte infections

被引:64
|
作者
Gnat, S. [1 ]
Lagowski, D. [1 ]
Nowakiewicz, A. [1 ]
机构
[1] Univ Life Sci, Fac Vet Med, Inst Biol Bases Anim Dis, Subdept Vet Microbiol, PL-20033 Lublin, Poland
关键词
dermatophytes; diagnostic; identification; resistance; treatment; TRICHOPHYTON-RUBRUM; GENE-EXPRESSION; ANTIFUNGAL SUSCEPTIBILITY; DRUG-RESISTANCE; DNA EXTRACTION; IN-VITRO; TIME; PCR; EPIDEMIOLOGY; AGENTS;
D O I
10.1111/jam.14611
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Dermatophytes are the aetiological factors of a majority of superficial fungal infections. What distinguishes them from other pathogenic filamentous fungi is their unique ability to degrade keratin. The remarkable ability of this group of fungi to survive in different ecosystems results from their morphological and ecological diversity as well as high adaptability to changing environmental conditions. Paradoxically, despite the progress in medicine, the prevalence of dermatophyte infections is increasing from year to year. At the beginning of the third millennium, practical diagnostic and therapeutic options are still very limited. This review focuses on understanding the major problems in this aspect of dermatophyte infections and indicates future strategies and perspectives for novel approaches to identification and drugs for elimination of dermatophytes. Particular importance is placed on development of a strategy for a diagnostic pathway and implementation of rapid and reliable diagnostics methods designed by international teams. Furthermore, among compounds that currently arouse great interest, representatives of terpenoids, alkaloids, saponins, flavonoids and essential oils deserve attention. Many of these compounds are undergoing clinical trials as potential antifungal agents, and future research should focus on attempts at determination of the applicability of tested substances. Finally, the advantages and disadvantages in implementation of new diagnostic paths and medicinal substances for routine use are indicated.
引用
收藏
页码:212 / 232
页数:21
相关论文
共 50 条
  • [1] GRISEOFULVIN AND KETOCONAZOLE IN THE TREATMENT OF DERMATOPHYTE INFECTIONS
    LAMBERT, DR
    SIEGLE, RJ
    CAMISA, C
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1989, 28 (05) : 300 - 304
  • [2] FAILURE OF TREATMENT IN CHRONIC DERMATOPHYTE INFECTIONS
    HAY, RJ
    POSTGRADUATE MEDICAL JOURNAL, 1979, 55 (647) : 608 - 610
  • [3] DERMATOPHYTE INFECTIONS
    CLAYTON, YM
    POSTGRADUATE MEDICAL JOURNAL, 1979, 55 (647) : 605 - 607
  • [4] TREATMENT OF CHILDHOOD DERMATOPHYTE INFECTIONS WITH ORAL TERBINAFINE
    GOULDEN, V
    GOODFIELD, MJD
    PEDIATRIC DERMATOLOGY, 1995, 12 (01) : 53 - 54
  • [5] DERMATOPHYTE INFECTIONS
    MACURA, AB
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (05) : 313 - 323
  • [6] Dermatophyte infections
    Hainer, BL
    AMERICAN FAMILY PHYSICIAN, 2003, 67 (01) : 101 - 108
  • [7] DERMATOPHYTE INFECTIONS
    LEBOZEC, P
    GAZETTE MEDICALE, 1989, 96 (30): : 45 - 51
  • [8] Molecular methods for dermatophyte infections - Summary after 12 years routine diagnostics
    Uhrlass, S.
    Krueger, C.
    Nenoff, P.
    MYCOSES, 2019, 62 : 32 - 32
  • [9] Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections
    Chen, Shiu-Jau
    Wang, Shao-Cheng
    Chen, Yuan-Chuan
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (12)
  • [10] Advances of liposomal mediated nanocarriers for the treatment of dermatophyte infections
    Mousavi, Seyed Amin Ayatollahi
    Mokhtari, Abnoos
    Barani, Mahmood
    Izadi, Alireza
    Amirbeigi, Alireza
    Ajalli, Narges
    Amanizadeh, Azam
    Hadizadeh, Sanaz
    HELIYON, 2023, 9 (08)